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Table. Outcomes of open and fenestrated endovascular aneurysm repair
(FEVAR) repair by risk strata
Risk strata Open, % (n ¼ 107) FEVAR, % (n ¼ 80) P
Low risk
Death 1 0 1
Complication
Cardiac 3 1 1
Pulmonary 12 5 .2
Renal 5 2 .4
Moderate risk
Death 7.5 8.7 .8
Complication
Cardiac 6 4 .3
Pulmonary 22 3 <.01
Renal 8 3 .1
High risk
Death 40 4 <.01
Complication
Cardiac 17 4 .2
Pulmonary 33 12 .07
Renal 26 4 .02
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Contemporary Management of Median Arcuate Ligament Syndrome
Provides Early Symptom Improvementy
Jesse A. Columbo, Thadeus L. Trus, Brian W. Nolan, Byron F. Santos
Aleman, Philip P. Goodney, Eva M. Rzucidlo, Richard J. Powell, Daniel
B. Walsh, David H. Stone. Dartmouth-Hitchcock Medical Center,
Lebanon, NH
Objectives: Optimal diagnosis and management of median arcuate lig-
ament syndrome (MALS) remains unclear in contemporary practice. The
advent and evolution of laparoscopic and endovascular techniques has redir-
ected management toward a less invasive therapeutic algorithm. This study
examined our contemporary outcomes of patients treated for MALS.
Methods: All patients treated for MALS at Dartmouth-Hitchcock
Medical Center from 2000 to 2013 were retrospectively reviewed. Demo-
graphics and comorbidities were recorded. Freedom from symptoms and
from reintervention were the primary end points. Functional quality of life
was assessed. Follow-up via clinic visits and telephone allowed quantitative
comparisons among patients.
Results: During the study interval, 21 patients (24% male), mean age,
37 years, were treated for MALS. All patients complained of abdominal pain
in the presence of a celiac stenosis, 17 (81%) reported weight loss at the time
of presentation, and 57% had a concomitant psychiatric history. Diagnostic
imaging most commonly used included duplex ultrasound (81%), computed
tomography angiography (66%), angiography (57%), and magnetic reso-
nance angiography (5%). All patients underwent initial laparoscopic MAL
release. Seven patients (33%) underwent subsequent celiac stent placement,
in the setting of recurrent or unresolved symptoms with persistent celiac ste-
nosis, at a mean interval of 49 days. Two patients required surgical bypass
after an endovascular intervention failed. At 6 months, freedom from symp-
toms was 73% and freedom from reintervention was 64%. Eighteen (81%)
patients reported early symptom improvement and weight gain, and 66%
were able to return to work.
Conclusions: A multidisciplinary treatment approach using initial
laparoscopic release and subsequent stent placement and bypass sur-
gery provides symptom improvement in most patients treated for
MALS. The potential placebo effect, however, remains uncertain. A
signiﬁcant minority of patients will require reintervention, justifying
longitudinal surveillance and better patient selection. Patients can
anticipate functional recovery, weight gain, and return to work with
treatment.
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Signiﬁcant Long-Term Predictors of Reintervention Following
Percutaneous Subclavian Artery Revascularization>
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Hass, John Campbell, Aravindra Nanjundappa, Mohit Srivastava, Patrick
Stone, Mark Bates, Ali AbuRahma. WestVirginiaUniversity,Charleston,WVa
Objectives: This study was conducted to determine long-term predic-
tors of reintervention after percutaneous subclavian artery revascularization
(PSAR).
Methods: This was a single-center retrospective review of patients
with a symptomatic subclavian artery who underwent PSAR between
January 1999 and December 2013. In-stent restenosis (ISR) was deﬁned
as stenosis $70% on duplex ultrasound and target vessel reintervention
(TVR) as the occurrence of a repeat intervention. Freedom from events
(ISR and TVR) was analyzed using Kaplan-Meier Curves. Cox regression
analysis was used to determine the signiﬁcant predictors of TVR and
restenosis.
Results: Of the 147 endovascular revascularization attempts, 145
were successful (98.6%). A total of 118 patients (76.3% female) received
initial subclavian interventions, and 19 (16.1%) required a secondary inter-
vention (at least one TVR), whereas eight required more than one reinter-
vention during the study period. Maximum follow up was 14.5 with a mean
6 standard error of the mean of 7.3 6 4.1 years. Patients were average ageyNew England Society for Vascular Surgery
>Eastern Vascular Societyof 64.1 years. Comorbidities included chronic hypertension (69.5%), dia-
betes (38.1%), peripheral vascular disease (25.4%), and tobacco use
(50.8%). Freedom from ISR and TVR at 1, 5, and 10 years was 93%,
83%, and 75%, and 94%, 87%, and 81%, respectively. Smoking increased
the likelihood of ISR (hazard ratio [HR], 5.3; 95% conﬁdence interval
[CI], 1.7-17.1; P ¼ .004), whereas the side of the intervention (right
side) and increased age at the time of the intervention (by decade) decreased
the likelihood of ISR (HR, 0.18; 95% CI, 0.03-0.83; P ¼ .028) and (HR,
0.50; 95% CI, 0.32-0.77; P ¼ .002), respectively. In the meantime, we
found that smoking increased the likelihood of TVR (HR, 3.1; 95% CI,
1.01-9.6; P ¼ .048), and that age (by decade) decreased the likelihood of
TVR (HR, 0.51l 95% CI, 0.32-0.82; P ¼ .006).
Conclusions: Percutaneous subclavian artery revascularizations are
feasible and durable, with satisfactory outcomes well beyond 10 years. Sec-
ondary interventions are common in smokers. Older age at onset and right
side disease were found to decrease the odds of ISR and TVR.
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Risk Stratiﬁed Analysis of Open Versus Fenestrated Repair of Complex
Abdominal Aortic Aneurysmsy
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Christopher J. Kwolek, Mark F. Conrad, Richard P. Cambria, Virendra I.
Patel. Massachusetts General Hospital, Boston, Mass
Objectives: Commercial availability of fenestrated stent grafts for
endovascular aneurysm repair (FEVAR) in the United States has expanded
options for patients with complex (juxtarenal or suprarenal) abdominal
aortic aneurysms (CAAA). This study evaluated outcomes of open vs
FEVAR repair of CAAA using the National Surgical Quality Improvement
Project (NSQIP) database.
Methods: The NSQIP Participant Use File (2012) was queried by
Current Procedural Terminology codes to identify patients undergoing
open repair or FEVAR. A previously developed and validated risk scoring
system was revalidated using open and FEVAR patients. It was used to
assign CAAA patients into risk strata, and outcomes of open and FEVAR
repair were analyzed by patient risk.
Results: This study included 294 open and 165 FEVAR repairs.
FEVAR patients were older (76 6 9 vs 71 6 9 years; P < .01), had periph-
eral vascular disease (18% vs 7% 6 9%; P ¼ .03), and did not have rupture
(0% vs 19%; P < .01). FEVAR had shorter operating room time (2006 130
vs 270 6 130 minutes; P < .01) and median length of stay (3 vs 8 days; P <
.01). FEVAR conﬁgurations involved 0 (71%), 1 (8%), 2 (2%), or 3 (19%)
visceral stents. Our risk prediction model had excellent ﬁt to open andyNew England Society for Vascular Surgery
Table. Patency rates
Patients
1-year primary
patency,
1-year primary
assisted patency,
1-year secondary
patency,
% (95% CI) % (95% CI) % (95% CI)
All patients 90 (82-96) 94 (87-98) 95 (88-99)
Bypass
AFB 88 (60-98) 94 (68-99) 100 (76-100)
Extra-anatomic 92 (81-97) 92 (81-97) 93 (83-98)
Endarterectomy 100 (40-100) 100 (40-100) 100 (40-100)
Other bypass 100 (52-100) 100 (52-100) 100 (52-100)
AFB, Aortobifemoral bypass; CI, conﬁdence interval.
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39% (n ¼ 177), 41% (n ¼ 187), and 20% (n ¼ 95) low-risk, intermediate-
risk, and high-risk patients, respectively. The comparative outcomes of open
vs FEVAR by risk strata are presented in the Table.
Conclusions: Favorable outcomes for FEVAR observed in high-risk
patients likely reﬂect differences in clinical presentation; however, this anal-
ysis of early experience with FEVAR suggests comparable outcomes for
open and FEVAR repair in low-risk and intermediate-risk patients.
Disclosures: R. T. Lancaster: Nothing to disclose; J. Mohebali: Nothing
to disclose;E.Twerdahl:Nothing to disclose;E.Ergul:Nothing to disclose;
C. J. Kwolek: Nothing to disclose; M. F. Conrad: Nothing to disclose;
R. P. Cambria: Nothing to disclose; V. I. Patel: Nothing to disclose
Aortoiliac Occlusive Disease: Role of Open Surgery in the
Endovascular Era>
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Kalapatapu, Ronald M. Fairman, Michael A. Golden. Hospital of the
University of Pennsylvania, Philadelphia, Pa
Objectives: Aortoiliac occlusive disease is a common manifestation of
peripheral vascular disease. As reﬂected by the changes made in the Inter-
Society Consensus for the Management of Peripheral Arterial Disease II
guidelines, endovascular therapy is now the preferred modality for treatment
in most patients. Some patients are not candidates for an endovascular
approach due to their anatomy or prior interventions. Other patients may
be better managed with open repair to preserve future endovascular options
and allow access for contralateral infrainguinal interventions. This study
investigated the indications for and outcomes of open operations for aortoil-
iac occlusive disease in a contemporary patient series.
Methods: Two afﬁliated hospitals’ prospective databases were sur-
veyed retrospectively. All patients who underwent an open operation for
aortoiliac occlusive disease during a 5-year period from 2008 to 2012
were included in the analysis. Statistical analysis was performed using the
Student t-test and Kaplan-Meier techniques.
Results: We identiﬁed 87 patients (69% male) who had open opera-
tions for aortoiliac occlusive disease. Mean follow up was 17.4 months.
Average patient age was 64 years, and mean American Society of Anesthe-
siologists score was 3.1. Procedures included 16 aortobifemoral bypasses, 4
aortic endarterectomies, 61 extra-anatomic bypasses, 6 other bypasses, and
9 involved a combined endovascular procedure. The primary indications for
surgery were chronic occlusive disease in 79 patients (22 rest pain, 18 tissue
loss, 39 claudication) and acute limb ischemia with threatened limb in eight
patients. The main indication for open operation in (84%) of patients was
extent of disease. Twenty-one percent underwent unsuccessful attempts atTable. Cost data from two academic medical centers
EVAR patient
Center A factors P Center B factors P
Iliac aneurysm .01 Transferred .01
CABG/PTCA <5 years .04 AAA diameter .04
Reduced EF .04
Elevated creat .02
EVAR procedural
Cover Int Iliac .006 Graft vendor .007
Other art proc .002 OR coiling .03
EBL <.0001 Unplanned ext .01
IVF <.0001 Art inj reg ext .01
Proc time <.0001 EBL .0007
IVF .002
Proc time .0001
Dysrhythmia .01 Return OR .01
Resp comp .02 ICU stay .049
Renal failure .04
AAA, Abdominal aortic aneurysm; CABG, coronary artery bypass grafting; CO
ejection fraction; EVAR, endovascular aneurysm repair; ICU, intensive care un
PTCA, percutaneous transluminal angioplasty.
>Eastern Vascular Societyendovascular treatment before open repair. Previous interventions were
common: 22% had prior failed bypass and 38% had prior failed endovascular
intervention. Patency rates at 1 year were as noted in the Table. The compli-
cation rate was 43%, and most were wound related. Major amputation rate
was 8%, and perioperative mortality was 3.4% (n ¼ 3).
Conclusions: In the setting of the current “endovascular ﬁrst” para-
digm, open surgery for aortoiliac occlusive disease remains an important
revascularization option, especially for patients with diffuse disease. Short-
term patency rates remain excellent, even in these patients who were either
not candidates for or failed endovascular treatment. Future vascular trainees
will continue to need these options in their armamentarium.
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Factors Impacting Cost in Elective Endovascular and Open Abdominal
Aortic Aneurysm Repairs at Two Centersy
Reshma Duffy,1 Robert Everett,2 Peter Callas,1 Daniel Bertges,1 Jens
Eldrup-Jorgensen,3 Christopher Healey,3 Christopher Jones,1 Marion
Couch,1 Gabe Crowl,1 Andrew Stanley1. 1University of Vermont,
Burlington, Vt; 2Lock Haven University, Lock Haven, Pa; 3Maine
Medical Center, Portland, Me
Objectives: Cost data from two academic medical centers were exam-
ined to determine patient characteristics and/or clinical events that are pre-
dictive of high cost hospitalizations after elective endovascular (EVAR) and
open (OAAA) abdominal aortic aneurysm repair. Elements of patient selec-
tion, operative performance, and postoperative complications were exam-
ined for their inﬂuence on cost.OAAA patient
Center A P Center B P
Red EF .04 CHF .03
COPD e meds .02 b-Blockers (protective) .04
Prior bypass .01 COPD-all .01
Transfer .048
Age .002
OAAA procedural
Anesthesia .05 Exposure <.0001
Exposure .002 EBL .03
Clamp position .0001 IVF .0004
EBL .004 Proc time <.0001
IVF .0003
Proc time .0004
Dysrhythmia <.0001 Dysrhythmia <.0001
Resp comp <.0001 Resp comp <.0001
Renal failure .008 Renal failure .0005
PD, chronic obstructive pulmonary disease; EBL, estimated blood loss; EF,
it; OAAA, open abdominal aortic aneurysm repair; OR, operating room;
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